Immunotherapy nrog canakinumab yuav ua rau muaj kev hloov pauv hauv lub cev tiv thaiv kab mobthiab tuaj yeem cuam tshuam nrog lub peev xwm ntawm cov qog hlwb kom loj hlob thiab sib kis. Muab spartalizumab thiab canakinumab ua ntej kev phais yuav ua haujlwm zoo dua li tsis muaj kev kho mob ua ntej kev phais hauv kev kho mob raum.
YPuas yog Lurbinectedin tshuaj kho lossis tshuaj tiv thaiv kab mob?
[Lurbinectedin] yog daim ntawv khomob tshiab.
Canakinumab ua haujlwm li cas?
Canakinumab ua haujlwm los ntawm kev thaiv qhov kev txiav txim ntawm IL-1beta rau lub sijhawm, inhibiting o uas yog tshwm sim los ntawm nws cov khoom ntau dhau.
Canakinumab nqi npaum li cas?
Canakinumab, uas inhibits interleukin 1β nyob rau hauv lub inflammatory cascade, tam sim no tau pom zoo los kho cov kab mob autoimmune tsis tshua muaj, xws li cov menyuam yaus idiopathic mob caj dab thiab mob ua npaws. Nws tam sim no US tus nqi lag luam yog kwv yees li $ 73 000 ib xyoos rau 150 mg muab txhua 3 lub hlis
Ilaris tswj hwm li cas?
ILARIS yog muab txhua yim lub lis piam raws li ib koob tshuaj via subcutaneous txhaj. Siv cov txheej txheem aseptic, rov ua dua txhua lub vial ntawm ILARIS los ntawm maj mam txhaj 1 mL ntawm cov dej tsis muaj tshuaj tua kab mob rau kev txhaj tshuaj nrog 1 mL syringe thiab 18 G x 2 koob.
Immunotherapy and the side effects
